Latest filing published 05 Oct 2017 for TuHURA Biosciences, Inc./NV, €13k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -20.8%Entry US$15,470.00 · Close at T+365 US$12,250.00
- -70.7%Entry US$40,827.50 · Close at T+365 US$11,952.50
- -57.4%Entry US$36,750.00 · Close at T+365 US$15,662.50
- +1443.9%Entry US$9,975.00 · Close at T+365 US$154,000.00
- -36.0%Entry US$21,875.00 · Close at T+365 US$14,000.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Scott Praill: trading record in brief
All filings by Scott Praill on record concern TuHURA Biosciences, Inc./NV. We count 11 filings; the first trade dates from 18 March 2014 and the latest from 5 October 2017.
On the market, this insider has only ever bought: 5 purchases, €81k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2017, the count stands at 3 purchases and no sales.
Half of the purchases are above €13k and half below. On 2 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 5 purchases show a median change of -29.6%, with the price up in 40% of them. These figures describe past trades and do not predict future prices.
Most recently, on 5 October 2017, the filings show an open-market purchase worth €13k in TuHURA Biosciences, Inc./NV. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Scott Praill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 17,500 shares@ US$0.85226.9% of flowCommon StockSEC:0001213900-17-010332:0Canonical exit: 3 Jan 2018 (T+90)
- 211 shares@ US$3.201.2% of flowCommon StockSEC:0001213900-17-010206:0
- 211 shares@ US$3.201.2% of flowCommon StockSEC:0001213900-17-007149:0
- 4,167 shares@ US$3.6028.4% of flowCommon StockSEC:0001213900-17-006886:0Canonical exit: 24 Sept 2017 (T+90)
- 9,500 shares@ US$2.1037.4% of flowCommon StockSEC:0001213900-17-006200:0Canonical exit: 4 Sept 2017 (T+90)
- 211 shares@ US$3.201.3% of flowCommon StockSEC:0001213900-17-003272:0
- 211 shares@ US$3.201.3% of flowCommon StockSEC:0001213900-17-000020:0
- 211 shares@ US$3.201.3% of flowCommon StockSEC:0001213900-16-017277:0
- 144 shares@ US$3.200.9% of flowCommon StockSEC:0001213900-16-015095:0
- 50,000 shares@ US$0.60Common StockSEC:0001013762-15-000731:0Canonical exit: 14 Oct 2015 (T+90)
- 10,000 shares@ US$1.30Common StockSEC:0001013762-14-000259:0Canonical exit: 16 Jun 2014 (T+90)
11 of 11 declarations